FFA
CORT icon

Farther Finance Advisors’s Corcept Therapeutics CORT Stock Holding History

Farther Finance Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$419K Buy
3,639
+2,632
+261% +$283K ﹤0.01% 1719
2026
Q2 		$87.7K Buy
1,007
+648
+181% +$39.1K ﹤0.01% 2808
2026
Q1 		$15.1K Sell
359
-446
-55% -$16.7K ﹤0.01% 3841
2025
Q4 		$28K Sell
805
-164
-17% -$12.9K ﹤0.01% 3206
2025
Q3 		$80.5K Buy
969
+59
+6% +$4.27K ﹤0.01% 2165
2025
Q2 		$66.8K Buy
910
+669
+278% +$48.5K ﹤0.01% 1986
2025
Q1 		$22.1K Buy
241
+72
+43% +$4.38K ﹤0.01% 2341
2024
Q4 		$8.52K Sell
169
-89
-34% -$4.66K ﹤0.01% 2446
2024
Q3 		$11.9K Sell
258
-2,479
-91% -$88.1K ﹤0.01% 2301
2024
Q2 		$89.4K Buy
2,737
+2,632
+2,507% +$72.1K ﹤0.01% 1177
2024
Q1 		$2.7K Sell
105
-28
-21% -$662 ﹤0.01% 2364
2023
Q4 		$4.32K Buy
133
+27
+25% +$741 ﹤0.01% 2045
2023
Q3 		$2.89K Buy
106
+5
+5% +$145 ﹤0.01% 1717
2023
Q2 		$2.25K Hold
101
– – ﹤0.01% 1716
2023
Q1 		$2.19K Hold
101
– – ﹤0.01% 1614
2022
Q4 		$2.05K Buy
+101
New +$2.53K ﹤0.01% 1439

Other funds holding CORT

VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Farther Finance Advisors's CORT Position: Q3 2026 in Review

Farther Finance Advisors increased its Corcept Therapeutics (CORT) stake by 261% in Q3 2026, buying an estimated $283K and bringing the position to 3,639 shares worth $419K. The position accounts for ﹤0.01% of the portfolio, ranked #1719.

Farther Finance Advisors first reported a position in CORT in Q4 2022 and has held it in 16 quarters since. 12 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Farther Finance Advisors held 3,639 shares of Corcept Therapeutics worth $419K as of Q3 2026.
  • Farther Finance Advisors bought 2,632 Corcept Therapeutics shares in Q3 2026, an estimated $283K.
  • Corcept Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1719 holding.
  • Farther Finance Advisors first reported a position in Corcept Therapeutics in Q4 2022 and has held it in 16 quarters since.
  • 12 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.